← Open Payments lookup

DOUGLAS LANGEMEIER: Open Payments

NPI 1528076171 · NEBRASKA CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$312 in 20 payments from 8 companies in 2025. Trend: 2023 $263 · 2024 $428 · 2025 $312

Food & beverage: $312
CompanyPaymentsAmount
Lilly USA, LLC9$132
Novo Nordisk Inc3$51
Novartis Pharmaceuticals Corporation2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
ABBVIE INC.1$20
Actelion Pharmaceuticals US, Inc.1$17
AstraZeneca Pharmaceuticals LP1$14
Amgen Inc.1$14

Products named: JARDIANCE, MOUNJARO, LEQVIO, Rybelsus, XIFAXAN, VRAYLAR, OPSUMIT, Ozempic.

Industry payments across NE — which companies pay providers there.